PURPOSE: Early-phase clinical trials (EPTs) have led to new, more effective treatment options for children with cancer. Despite the extensive use of EPTs in pediatric oncology, little is known about parent and child experiences during EPT participation. The purposes of this pilot study were to assess the feasibility and preliminary results of having children with cancer and their parents complete measures of treatment burden and quality of life (QOL) concurrent with EPT participation. METHODS: In this descriptive, longitudinal, pilot study, parents and children were followed for the first 60 days of an EPT. Feasibility was assessed by participant enrollment and retention and completion of measures. Measures completed included the following: demographic form (completed at baseline); Diary of Trial Experiences to capture treatment burden (completed ongoing); and PedsQL™ Quality of Life Inventories, Cancer Modules, and Family Impact Module (completed at baseline, post-first disease evaluation, and off-study). Data were analyzed using descriptive statistics. RESULTS: Feasibility goals of enrollment, retention, and measure completion were partially met. Preliminary treatment burden and QOL results are provided. CONCLUSIONS: While QOL assessments may provide insight into EPT experiences, future studies need to be conducted at multiple sites and enrollment goals must account for participant attrition.
PURPOSE: Early-phase clinical trials (EPTs) have led to new, more effective treatment options for children with cancer. Despite the extensive use of EPTs in pediatric oncology, little is known about parent and child experiences during EPT participation. The purposes of this pilot study were to assess the feasibility and preliminary results of having children with cancer and their parents complete measures of treatment burden and quality of life (QOL) concurrent with EPT participation. METHODS: In this descriptive, longitudinal, pilot study, parents and children were followed for the first 60 days of an EPT. Feasibility was assessed by participant enrollment and retention and completion of measures. Measures completed included the following: demographic form (completed at baseline); Diary of Trial Experiences to capture treatment burden (completed ongoing); and PedsQL™ Quality of Life Inventories, Cancer Modules, and Family Impact Module (completed at baseline, post-first disease evaluation, and off-study). Data were analyzed using descriptive statistics. RESULTS: Feasibility goals of enrollment, retention, and measure completion were partially met. Preliminary treatment burden and QOL results are provided. CONCLUSIONS: While QOL assessments may provide insight into EPT experiences, future studies need to be conducted at multiple sites and enrollment goals must account for participant attrition.
Entities:
Keywords:
pediatric oncology; phase I clinical trial; quality of life; treatment burden
Authors: E J Sherman; D G Pfister; H S Ruchlin; D M Rubin; M H Radzyner; G H Kelleher; S F Slovin; W K Kelly; H I Scher Journal: Cancer Date: 2001-02-15 Impact factor: 6.860
Authors: Daniel A Morgenstern; Darren Hargrave; Lynley V Marshall; Susanne A Gatz; Giuseppe Barone; Tracey Crowe; Kathy Pritchard-Jones; Stergios Zacharoulis; Donna L Lancaster; Sucheta J Vaidya; Julia C Chisholm; Andrew D J Pearson; Lucas Moreno Journal: J Pediatr Hematol Oncol Date: 2014-04 Impact factor: 1.289
Authors: Addie C Wootten; Jo M Abbott; Heather M Siddons; Mark A Rosenthal; Anthony J Costello Journal: Support Care Cancer Date: 2009-12-04 Impact factor: 3.603
Authors: Aerang Kim; Elizabeth Fox; Katherine Warren; Susan M Blaney; Stacey L Berg; Peter C Adamson; Madeleine Libucha; Elena Byrley; Frank M Balis; Brigitte C Widemann Journal: Oncologist Date: 2008-06
Authors: Lehana Thabane; Jinhui Ma; Rong Chu; Ji Cheng; Afisi Ismaila; Lorena P Rios; Reid Robson; Marroon Thabane; Lora Giangregorio; Charles H Goldsmith Journal: BMC Med Res Methodol Date: 2010-01-06 Impact factor: 4.615
Authors: David T Eton; Djenane Ramalho de Oliveira; Jason S Egginton; Jennifer L Ridgeway; Laura Odell; Carl R May; Victor M Montori Journal: Patient Relat Outcome Meas Date: 2012-08-24